ÂÜÀòÂÒÂ×

Nigel Saunders has an extensive work experience in the field of biotech and academia. Nigel'smost recent role is as the Chief Scientific Officer at GENPAX AG, where they are involved in the development of GenPAx, an innovation for Precision Medicine directed at Pathogen Analysis. Prior to this, they held the position of Chair of Systems and Synthetic Biology at Brunel University London, where they also served as the University Strategic Research Institute Theme Leader for Synthetic Biology. Nigel'swork focused on interdisciplinary research in synthetic biology, systems biology, and evolutionary and comparative genomics.

Before joining Brunel University London, Nigel worked as a Lecturer and then a Senior Research Fellow at Somerville College, University of Oxford. Nigel also held various positions at the University of Oxford, including Reader in Pathology/Microbiology, Wellcome Trust Advanced Research Fellow, and Wellcome Trust Research Fellow in Medical Microbiology. Nigel'sresearch at Oxford involved bacterial pathogenesis, functional genomics, and bioinformatics.

Nigel has also been affiliated with University College, Oxford as a Special Supernumerary Fellow, and Magdalen College, University of Oxford as a Lecturer. Early in their career, they worked as a Registrar in Bacteriology and Infectious Disease at the Royal Postgraduate Medical School/Hammersmith Hospital and as a Junior House Officer at Aberdeen Royal Infirmary.

Overall, Nigel Saunders has made significant contributions to the fields of biotech, synthetic biology, bacterial pathogenesis, genomics, and bioinformatics through their academic and industry roles.

Nigel Saunders first completed their undergraduate studies at the University of Aberdeen from 1983 to 1990, where they obtained a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree. During this time, they also earned a Bachelor of Medical Biology (B. Med. Biol) degree with a focus on Pathology/Experimental Pathology from the same university in 1985-1986. Nigel then pursued higher education at Queen Mary University of London, where they obtained a Master of Science (M.Sc.) degree in Medical Microbiology and Bacteriology from 1992 to 1994. Following this, they pursued a Doctor of Philosophy (PhD) degree at the University of Oxford from 1995 to 1998, specializing in Bacterial Pathogenesis and Genomics.